Adeno-associated virus 2 was present in high amounts in liver tissue and blood in nearly all the children with unexplained hepatitis in the studies. And it was only rarely found in healthy kids, those ...

Austin, TX, USA, Feb. 03, 2026 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Adeno Associated Virus Vector Manufacturing Market Size, Trends and Insights By ...

Bayer has discontinued an early-stage clinical gene therapy for a rare genetic disorder in favor of a similar candidate. | Bayer has discontinued an early-stage clinical gene therapy for a rare ...

DUBLIN--(BUSINESS WIRE)--The "Adeno Associated Virus Vector Manufacturing Market Size, Share & Trends Analysis Report By Scale Of Operations (Clinical, Commercial), By Method, By Application, By ...

A novel bioengineering strategy utilizing peptide display technology on the AAV1 capsid has successfully generated next-generation viral vectors with ...

There is no need to waste important AAV samples. Bio-Techne’s automated, high-throughput systems allow the characterization of AAVs in sample volumes as low as 3 µL while maintaining high levels of ...

Adeno Associated Virus Vector Manufacturing Market · GlobeNewswire Inc. Dublin, Jan. 26, 2026 (GLOBE NEWSWIRE) -- The "Adeno Associated Virus Vector Manufacturing Market - Global Industry Size, Share, ...

AFTX-201 uses a proprietary capsid to deliver a human BAG3 transgene, aiming to restore cardiac function with lower doses than conventional gene therapies.

Scientists in the United Kingdom say they've found "strong circumstantial evidence" linking an obscure type of sidekick virus called adeno-associated virus to unexplained cases of liver damage in ...